TY - JOUR
T1 - Brief assessment of cognitive function in myotonic dystrophy
T2 - Multicenter longitudinal study using computer-assisted evaluation
AU - Myotonic Dystrophy Clinical Research Network
AU - Deutsch, Gayle K.
AU - Hagerman, Katharine A.
AU - Sampson, Jacinda
AU - Dent, Gersham
AU - Dekdebrun, Jeanne
AU - Parker, Dana M.
AU - Thornton, Charles A.
AU - Heatwole, Chad R.
AU - Subramony, Sub H.
AU - Mankodi, Ami K.
AU - Ashizawa, Tetsuo
AU - Statland, Jeffrey M.
AU - Arnold, W. David
AU - Moxley, Richard T.
AU - Day, John W.
N1 - Funding Information:
G.K.D. served as a consultant to Biogen. K.A.H. received grant support from Biogen.
Funding Information:
The authors thank the participants and families of the Myotonic Dystrophy Clinical Research Networks longitudinal study.
Funding Information:
National Institute of Neurological Disorders & Stroke, Grant Number: P50NS048843; the Muscular Dystrophy Association, Grant Number: MDA627906; the Myotonic Dystrophy Foundation; the Marigold Foundation; and Biogen. Funding information
Publisher Copyright:
© 2022 Wiley Periodicals LLC.
PY - 2022/5
Y1 - 2022/5
N2 - INTRODUCTION/AIMS: Myotonic dystrophy type 1 (DM1) is known to affect cognitive function, but the best methods to assess central nervous system involvement in multicenter studies have not been determined. In this study our primary aim was to evaluate the potential of computerized cognitive tests to assess cognition in DM1.METHODS: We conducted a prospective, longitudinal, observational study of 113 adults with DM1 at six sites. Psychomotor speed, attention, working memory, and executive functioning were assessed at baseline, 3 months, and 12 months using computerized cognitive tests. Results were compared with assessments of muscle function and patient reported outcomes (PROs), including the Myotonic Dystrophy Health Index (MDHI) and the 5-dimension EuroQol (EQ-5D-5L) questionnaire.RESULTS: Based on intraclass correlation coefficients, computerized cognitive tests had moderate to good reliability for psychomotor speed (0.76), attention (0.82), working memory speed (0.79), working memory accuracy (0.65), and executive functioning (0.87). Performance at baseline was lowest for working memory accuracy (P < .0001). Executive function performance improved from baseline to 3 months (P < .0001), without further changes over 1 year. There was a moderate correlation between poorer executive function and larger CTG repeat size (r = -0.433). There were some weak associations between PROs and cognitive performance.DISCUSSION: Computerized tests of cognition are feasible in multicenter studies of DM1. Poor performance was exhibited in working memory, which may be a useful variable in clinical trials. Learning effects may have contributed to the improvement in executive functioning. The relationship between PROs and cognitive impairment in DM1 requires further study.
AB - INTRODUCTION/AIMS: Myotonic dystrophy type 1 (DM1) is known to affect cognitive function, but the best methods to assess central nervous system involvement in multicenter studies have not been determined. In this study our primary aim was to evaluate the potential of computerized cognitive tests to assess cognition in DM1.METHODS: We conducted a prospective, longitudinal, observational study of 113 adults with DM1 at six sites. Psychomotor speed, attention, working memory, and executive functioning were assessed at baseline, 3 months, and 12 months using computerized cognitive tests. Results were compared with assessments of muscle function and patient reported outcomes (PROs), including the Myotonic Dystrophy Health Index (MDHI) and the 5-dimension EuroQol (EQ-5D-5L) questionnaire.RESULTS: Based on intraclass correlation coefficients, computerized cognitive tests had moderate to good reliability for psychomotor speed (0.76), attention (0.82), working memory speed (0.79), working memory accuracy (0.65), and executive functioning (0.87). Performance at baseline was lowest for working memory accuracy (P < .0001). Executive function performance improved from baseline to 3 months (P < .0001), without further changes over 1 year. There was a moderate correlation between poorer executive function and larger CTG repeat size (r = -0.433). There were some weak associations between PROs and cognitive performance.DISCUSSION: Computerized tests of cognition are feasible in multicenter studies of DM1. Poor performance was exhibited in working memory, which may be a useful variable in clinical trials. Learning effects may have contributed to the improvement in executive functioning. The relationship between PROs and cognitive impairment in DM1 requires further study.
KW - muscle disease
KW - myotonic dystrophy type 1
KW - neuropsychology
KW - patient-reported outcome
KW - quality of life
KW - Computers
KW - Reproducibility of Results
KW - Prospective Studies
KW - Humans
KW - Cognition
KW - Myotonic Dystrophy/complications
KW - Adult
KW - Longitudinal Studies
UR - http://www.scopus.com/inward/record.url?scp=85128800269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128800269&partnerID=8YFLogxK
U2 - 10.1002/mus.27520
DO - 10.1002/mus.27520
M3 - Article
C2 - 35179228
AN - SCOPUS:85128800269
SN - 0148-639X
VL - 65
SP - 560
EP - 567
JO - Muscle and Nerve
JF - Muscle and Nerve
IS - 5
ER -